πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

5,027 results for β€œERA” Clear

  1. transdermal nicotine replacement therapy

    BRIGHT MINDS BIOSCIENCES INC.

    Smoking

    approved small molecule active

    1 trial
  2. treprostinil sodium

    United Therapeutics Europe Ltd

    Pulmonary Arterial Hypertension

    approved small molecule completed

    1 trial
  3. treprostinil sodium

    United Therapeutics Europe Ltd

    Hypertension, Pulmonary

    approved small molecule terminated

    2 trials
  4. treprostinil sodium

    United Therapeutics Europe Ltd

    Pulmonary Hypertension

    approved small molecule completed

    1 trial
  5. umeclidinium 62.5 Β΅g and vilanterol 25 Β΅g

    Theravance Biopharma Ireland Umited

    COPD (Chronic Obstructive Pulmonary Disease)

    approved small molecule active

    1 trial
  6. valdecoxib

    Pfizer

    Pain, Postoperative

    approved small molecule completed

    1 trial
  7. 20 grams protein

    United Therapeutics Europe Ltd

    Muscle Disuse

    other active

    1 trial
  8. 24/7 EEGβ„’ SubQ

    COGNITION THERAPEUTICS INC

    Sleep

    other completed

    1 trial
  9. 3T MR Imaging of the cervical spinal cord

    United Therapeutics Europe Ltd

    Cervical Spondylosis With Myelopathy

    other active

    1 trial
  10. 4D

    4D Molecular Therapeutics

    Dietary Supplementation

    other completed

    1 trial
  11. 89Zr-trastuzumab

    United Therapeutics Europe Ltd

    Breast Cancer Metastases

    other completed

    1 trial
  12. 95% condensed proanthocyanidins from grape seed extract

    United Therapeutics Europe Ltd

    Iron Deficiency Anemia

    other completed

    1 trial
  13. A single dose of liposomal bupivacaine is administered at the conclusion of surgery without adjunctive analgesics, followed by a supplemental dose 72 hours postoperatively.

    The First People's Hospital of Lianyungang

    Anal Fistula

    small molecule active

    1 trial
  14. Abciximab local infusion

    Atrium Therapeutics

    Acute Anterior Myocardial Infarction

    small molecule completed

    1 trial
  15. Accelerated partial breast irradiation

    Universal Integrated

    Breast Cancer

    other active

    1 trial
  16. Albumin Human

    United Therapeutics Europe Ltd

    Burn Injury

    small molecule completed

    1 trial
  17. Allergy immunotherapy ("allergy shots")

    United Therapeutics Europe Ltd

    Eosinophilic Esophagitis

    mab terminated

    1 trial
  18. Amino acid based formula

    United Therapeutics Europe Ltd

    Cow Milk Allergy

    other completed

    1 trial
  19. Amivita

    Wujin People's Hospital

    Amyotrophic Lateral Sclerosis

    small molecule active

    1 trial
  20. Anti-infective therapy

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Bronchiectasis Adult

    small molecule active

    1 trial
  21. AntiPlatelet therapy

    The First People's Hospital of Lianyungang

    Coronary Artery Disease

    small molecule active

    1 trial
  22. Antioxidant Berry Supplementation

    United Therapeutics Europe Ltd

    Heat Intolerance

    other completed

    1 trial
  23. Apolipoprotein (ApoE) detection

    Grace Therapeutics

    Senile Plaques

    gene therapy active

    1 trial
  24. Apple Cider Vinegar

    United Therapeutics Europe Ltd

    Kidney Stones, Urolithiasis, Hypocitraturia

    other active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources